Literature DB >> 25192935

Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming.

Martin Picard1, Jiangwen Zhang2, Saege Hancock3, Olga Derbeneva1, Ryan Golhar4, Pawel Golik5, Sean O'Hearn6, Shawn Levy7, Prasanth Potluri1, Maria Lvova1, Antonio Davila1, Chun Shi Lin1, Juan Carlos Perin8, Eric F Rappaport8, Hakon Hakonarson3, Ian A Trounce9, Vincent Procaccio10, Douglas C Wallace11.   

Abstract

Variation in the intracellular percentage of normal and mutant mitochondrial DNAs (mtDNA) (heteroplasmy) can be associated with phenotypic heterogeneity in mtDNA diseases. Individuals that inherit the common disease-causing mtDNA tRNA(Leu(UUR)) 3243A>G mutation and harbor ∼10-30% 3243G mutant mtDNAs manifest diabetes and occasionally autism; individuals with ∼50-90% mutant mtDNAs manifest encephalomyopathies; and individuals with ∼90-100% mutant mtDNAs face perinatal lethality. To determine the basis of these abrupt phenotypic changes, we generated somatic cell cybrids harboring increasing levels of the 3243G mutant and analyzed the associated cellular phenotypes and nuclear DNA (nDNA) and mtDNA transcriptional profiles by RNA sequencing. Small increases in mutant mtDNAs caused relatively modest defects in oxidative capacity but resulted in sharp transitions in cellular phenotype and gene expression. Cybrids harboring 20-30% 3243G mtDNAs had reduced mtDNA mRNA levels, rounded mitochondria, and small cell size. Cybrids with 50-90% 3243G mtDNAs manifest induction of glycolytic genes, mitochondrial elongation, increased mtDNA mRNA levels, and alterations in expression of signal transduction, epigenomic regulatory, and neurodegenerative disease-associated genes. Finally, cybrids with 100% 3243G experienced reduced mtDNA transcripts, rounded mitochondria, and concomitant changes in nuclear gene expression. Thus, striking phase changes occurred in nDNA and mtDNA gene expression in response to the modest changes of the mtDNA 3243G mutant levels. Hence, a major factor in the phenotypic variation in heteroplasmic mtDNA mutations is the limited number of states that the nucleus can acquire in response to progressive changes in mitochondrial retrograde signaling.

Entities:  

Keywords:  RNA-Seq; electron microscopy; epigenetic; mitochondrial disease; mtDNA variant

Mesh:

Substances:

Year:  2014        PMID: 25192935      PMCID: PMC4183335          DOI: 10.1073/pnas.1414028111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

Authors:  Valerie Desquiret-Dumas; Naig Gueguen; Magalie Barth; Arnaud Chevrollier; Saege Hancock; Douglas C Wallace; Patrizia Amati-Bonneau; Daniel Henrion; Dominique Bonneau; Pascal Reynier; Vincent Procaccio
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 2.  Mitochondrial morphology transitions and functions: implications for retrograde signaling?

Authors:  Martin Picard; Orian S Shirihai; Benoit J Gentil; Yan Burelle
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-01-30       Impact factor: 3.619

3.  A mitochondrial bioenergetic etiology of disease.

Authors:  Douglas C Wallace
Journal:  J Clin Invest       Date:  2013-04-01       Impact factor: 14.808

4.  Epigenetic silencing mediates mitochondria stress-induced longevity.

Authors:  Elizabeth A Schroeder; Nuno Raimundo; Gerald S Shadel
Journal:  Cell Metab       Date:  2013-06-04       Impact factor: 27.287

Review 5.  Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism.

Authors:  Arnaud Chevrollier; Dominique Loiseau; Pascal Reynier; Georges Stepien
Journal:  Biochim Biophys Acta       Date:  2010-10-13

6.  Epigenetic regulation of motor neuron cell death through DNA methylation.

Authors:  Barry A Chestnut; Qing Chang; Ann Price; Catherine Lesuisse; Margaret Wong; Lee J Martin
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

7.  A systems approach for decoding mitochondrial retrograde signaling pathways.

Authors:  Sehyun Chae; Byung Yong Ahn; Kyunghee Byun; Young Min Cho; Myeong-Hee Yu; Bonghee Lee; Daehee Hwang; Kyong Soo Park
Journal:  Sci Signal       Date:  2013-02-26       Impact factor: 8.192

Review 8.  Mitochondria and cancer.

Authors:  Douglas C Wallace
Journal:  Nat Rev Cancer       Date:  2012-10       Impact factor: 60.716

9.  Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.

Authors:  Christopher J Klein; Maria-Victoria Botuyan; Yanhong Wu; Christopher J Ward; Garth A Nicholson; Simon Hammans; Kaori Hojo; Hiromitch Yamanishi; Adam R Karpf; Douglas C Wallace; Mariella Simon; Cecilie Lander; Lisa A Boardman; Julie M Cunningham; Glenn E Smith; William J Litchy; Benjamin Boes; Elizabeth J Atkinson; Sumit Middha; P James B Dyck; Joseph E Parisi; Georges Mer; David I Smith; Peter J Dyck
Journal:  Nat Genet       Date:  2011-05-01       Impact factor: 38.330

10.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  118 in total

Review 1.  Mitochondrial Aspartate/Glutamate Carrier SLC25A12 and Autism Spectrum Disorder: a Meta-Analysis.

Authors:  Yuta Aoki; Samuele Cortese
Journal:  Mol Neurobiol       Date:  2015-02-10       Impact factor: 5.590

Review 2.  Mitochondrial health, the epigenome and healthspan.

Authors:  Miguel A Aon; Sonia Cortassa; Magdalena Juhaszova; Steven J Sollott
Journal:  Clin Sci (Lond)       Date:  2016-08-01       Impact factor: 6.124

3.  Metabolic rescue in pluripotent cells from patients with mtDNA disease.

Authors:  Hong Ma; Clifford D L Folmes; Jun Wu; Robert Morey; Sergio Mora-Castilla; Alejandro Ocampo; Li Ma; Joanna Poulton; Xinjian Wang; Riffat Ahmed; Eunju Kang; Yeonmi Lee; Tomonari Hayama; Ying Li; Crystal Van Dyken; Nuria Marti Gutierrez; Rebecca Tippner-Hedges; Amy Koski; Nargiz Mitalipov; Paula Amato; Don P Wolf; Taosheng Huang; Andre Terzic; Louise C Laurent; Juan Carlos Izpisua Belmonte; Shoukhrat Mitalipov
Journal:  Nature       Date:  2015-07-15       Impact factor: 49.962

Review 4.  The Potential Application of Mitochondrial Medicine in Toxicologic Poisoning.

Authors:  David H Jang; Joshua W Lampe; Lance B Becker
Journal:  J Med Toxicol       Date:  2015-06

Review 5.  Integrating mitochondriomics in children's environmental health.

Authors:  Kelly J Brunst; Andrea A Baccarelli; Rosalind J Wright
Journal:  J Appl Toxicol       Date:  2015-06-05       Impact factor: 3.446

Review 6.  Mitochondrial dysfunction and mitochondrial dynamics-The cancer connection.

Authors:  Satish Srinivasan; Manti Guha; Anna Kashina; Narayan G Avadhani
Journal:  Biochim Biophys Acta Bioenerg       Date:  2017-01-16       Impact factor: 3.991

7.  Mitochondrial DNA 3243A>G heteroplasmy is associated with changes in cytoskeletal protein expression and cell mechanics.

Authors:  Judith Kandel; Martin Picard; Douglas C Wallace; David M Eckmann
Journal:  J R Soc Interface       Date:  2017-06       Impact factor: 4.118

8.  The second genome: Effects of the mitochondrial genome on cancer progression.

Authors:  Adam D Scheid; Thomas C Beadnell; Danny R Welch
Journal:  Adv Cancer Res       Date:  2019-02-27       Impact factor: 6.242

Review 9.  Mitophagy in cardiovascular homeostasis.

Authors:  Ruohan Zhang; Judith Krigman; Hongke Luo; Serra Ozgen; Mingchong Yang; Nuo Sun
Journal:  Mech Ageing Dev       Date:  2020-04-11       Impact factor: 5.432

10.  Stress and Psychiatric Disorders: The Role of Mitochondria.

Authors:  Teresa E Daniels; Elizabeth M Olsen; Audrey R Tyrka
Journal:  Annu Rev Clin Psychol       Date:  2020-02-24       Impact factor: 18.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.